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1. Introduction 
Deep venous thrombosis (DVT) and pulmonary embolism (PE) constitute clinical 
presentations of the same vascular disease, known as venous thromboembolism (VTE). VTE 
is responsible for hospitalization of >250000 Americans annually. It is associated with high 
morbidity and mortality and represents a primary cause of preventable death. There is 
strong evidence that obesity is an independent risk factor for DVT and PE. Bariatric surgery 
is proven to be an effective means in the therapy of morbid obesity and its related co-
morbidities, thus its prevalence is rapidly increasing. Well established and widely 
performed procedures include laparoscopic adjustable gastric band (LAGB), Roux-en-Y 
gastric bypass (RYGBP), biliopancreatic diversion (BPD, with or without duodenal switch) 
and sleeve gastrectomy (SG). LAGB is a purely restrictive method, while RYGBP and BPD 
are considered as mainly malabsorbptive procedures. SG was performed as a bridge to 
further by-pass surgery, however nowadays is performed as a single stage procedure. The 
risk of VTE in patients undergoing elective bariatric surgery is high, attributable to obesity, 
intraoperating factors and the lack of an established guidance describing optimal VTE 
prophylaxis. Overall incidence of VTE in this population is reported to be 1-3%. Diagnosis of 
PE postoperatively in obese patients can be difficult due to physical limitations and 
consequently may be underdiagnosed. Furthermore, although VTE is usually diagnosed as 
immediate postoperative complication, PE can occur in nonhospitalized patients, within the 
first month after surgery, despite pharmacologic prophylaxis. 
2. Obesity 
The most widely applied tool to diagnose obesity is body mass index (BMI). BMI is defined 
as weight in kilograms divided by the square of height in meters. World health 
Organization defines obesity as a BMI≥ 30. This cutoff was selected because according to 
epidemiological studies mortality curve increases at this value. Moreover, morbid obesity is 
defined as BMI≥40. 
The prevalence of obesity increases rapidly in both developed and developing countries and 
is considered as one of the most serious public health problems.  
Recent scientific data from long-term studies support the strong association between obesity 
and type 2 diabetes, hypertension, cardiovascural disease, dyslipidemia, arthritis, 
gallbladder disease, sleep apnea syndrome and many types of cancer. Furthermore, obesity 
deteriorates quality of life and induces severe psychological disorders. 
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3. Bariatric surgery 
Bariatric surgery holds an important and well established role in the management of obese 
and morbid obese patients. Furthermore, it is proved to be the most efficient mode of 
treatment that provides sustained weight loss in morbidly obese patients.  
International medical and surgical societies (International Federation for the Surgery of 
Obesity (IFSO), European Association for Study of Obesity (EASO), European Childhood 
Obesity Group (ECOG)) created guidelines in order to assure safe and effective clinical 
practice in the field of bariatric surgery. 
3.1 Indications of bariatric surgery 
a. Patients from 18-60 years 
- with BMI≥40 kg/m2 
- with BMI 35-40 kg/m2 and with co-morbidity which weight loss is expected to improve 
(metabolic disorders, cardio-respiratory disease, severe joint disease, obesity-induced 
severe psychological problems) 
To be candidates for surgical management, patients must have failed to lose weight or to 
maintain a substantial weight-loss following conservative treatment. 
Bariatric surgery is indicated in patients who managed to lose weight prior to scheduled 
surgery and have reach a BMI below the required for surgery.  
b. Patients aged above 60 
In these patients the primary objective is to improve quality of life. Benefits should be 
contemplated with potential risks, thus indications for surgery should be individualized. 
3.2 Contraindications of bariatric surgery 
- Absence of effort to lose weight following an appropriate non-surgical medical 
program. 
- Psychotic disorders, severe depression, personality disorders. 
- Alcohol abuse and/or drug dependencies. 
- Life-threatening diseases (in a short term). 
- Patients who are unable to care for themselves or to participate and conform to the 
required long-term medical follow-up. 
- Patients in very high or unacceptable anaesthetic risk. 
3.3 Bariatric surgery techniques 
Nowadays a variety of surgical procedures is available for the surgical treatment of obesity. 
Furthermore, although primary objective of bariatric surgery is the weight loss, significant 
long-term amelioration or total remission of co-morbidities has been established. Bariatric 
surgery procedures modify the gastrointestinal track in order to reduce its volume and/or 
its absorptive function.  
Restrictive procedures induce volume limitation and include laparoscopic adjustable gastric 
band (LAGB), vertical banded gastroplasty (VBG), laparoscopic sleeve gastrectomy (LSG), 
gastric bypass (GBP).  
Malabsorptive procedures induce limited absorption of nutrients and include 
biliopancreatic diversion with (BPD-DS) or without duodenal switch (BPD). 
Roux-en-Y gastric bypass (RYGBP), open or laparoscopic, encompasses characteristics of 
both types of procedures, as it provides restriction and mild- malabsorption. 
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4. Venous thromboembolism 
4.1 Predisposing factors to venous thromboembolism in bariatric surgery 
Morbid (BMI>50) and truncal obesity are identified as major predisposing factors for VTE. 
Sedentary lifestyle, increased abdominal pressure and excessive weight resting on the 
inferior vena cava drainage attribute to the increased risk. Additional risk factors include 
advanced age, history of previous VTE, immobilization, venous insufficiency and stasis, 
smoking, estrogen- containing oral contraceptives and hormone replacement therapy, 
hypercoaguable state, hypoventilation syndrome and anastomotic leakage. According to 
current literature, obesity interferes in intrinsic and extrinsic coagulation pathways, as well 
as in the anticoagulant mechanism, leading to a hypercoagulating state. Plasma 
concentration of fibrogen, von Willebrand, t-PA, PAI-1 and factor VII are significantly 
elevated in obese patients, while platelet aggregation is promoted due to leptin. There is 
evidence that treatment of morbid obesity can reverse partially some of the above 
abnormalities, as weight loss is associated with significant reduction in fibrogen, t-PA, PAI-1 
and improvement of deficiency of antithrombin III. 
Perioperative factors contributing to VTE include extend of surgical trauma, operative 
duration, length of postoperative immobilization and the use of general versus regional 
anesthesia. The risk of developing VTE depends on the type of major abdominal surgical 
procedure. Mukherjee et al. reported lower incidence of VTE among bariatric surgery 
patients (0.35%), while VTE rates were higher in patients undergoing nephrectomy, 
hepatectomy, colorectal resection, splenectomy, gastrectomy, pancreatectomy and 
esophagectomy. This lower rate may reflect strict adherence of bariatric surgeons to VTE 
prophylaxis guidelines relative to other surgical specialties.  
More specifically, in laparoscopic bariatric surgery, reverse Trendelenburg position and 
pneumoperitoneum are associated with venous stasis of lower extremity and impaired 
venous return due to the compression of iliac veins and inferior vena cava. Furthermore 
several studies show the development of a hypercoagulable state during laparoscopy. 
Conversely, the risk of VTE during laparoscopy could be compensated by lower degree of 
surgical injury, early mobilization and reduced postoperative acute-phase response. Podnos 
et al. in a review of 3464 cases of GBP demonstrated that although the difference was not 
statistically significant, the incidence of PE was lower in laparoscopic group rather than the 
open group. In absence of randomized controlled studies, the evidence remains inconclusive 
as to the relative risk of VTE after laparoscopic bariatric surgery. 
4.2 Prophylaxis of venous thromboembolism in bariatric surgery 
4.2.1 Mechanical prophylaxis 
Mechanical modalities include graduated compression stockings, intermittent pneumatic 
compression devices (IPC) and venous foot pump. Perioperative use of the above devices and 
early mobilization of patients reduce the risk of VTE by increasing venous outflow and 
preventing venous stasis. Remarkable advantage of mechanical prophylaxis is lack of 
interference in the coagulation path, which renders it safe for patients in high risk for bleeding. 
Limitations of the use of mechanical devices are skin irritation and poor compliance.  
4.2.2 Pharmacological prophylaxis 
Unfractionated heparin (UFH) and low molecular weight heparins (LMWH) are effective in 
the prophylaxis of VTE in surgical patients. An initial dose of 5000 units UFH is 
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administrated subcutaneous preoperatively and repeated doses every 8 or 12 hours are 
required. On the contrary, LMWH shows improved pharmacological characteristics, as it 
requires a single dose per day, has lower degree of plasma protein binding, longer half-life 
and an enhanced bioavailability. Contraindications in anticoagulation agents are allergy, 
heparin-induced thrombocytopenia, coagulation disorders, active bleeding or patient at 
high risk of bleeding. 
There is no consensus in literature considering the optimal regimen, dosage, and duration or 
application mode for VTE preventions in bariatric surgery patients. Furthermore, there is a 
paucity of data confirming the scaling of dosage according to body weight and renal 
function. Several authors support low rate of VTE when weight-adapted dosages are 
administrated, while others suggest that there is no significant difference. American College 
of Chest Physicians recommend the administration of  LMWH, UFH 3 times daily, 
fontaparinux or the combination of one of these pharmacologic method with optimally used 
IPC (Grade 1C). Although according to recommendations administrated doses should be 
higher than those for nonobese patients (Grade 2C), adjusting doses according to BMI 
remain debatable. Current statement of American Society for Metabolic and Bariatric 
Surgery suggests the use of both mechanical and pharmacological prophylaxis in bariatric 
patients, without providing further adaptation guidance. Data on compliance of bariatric 
surgeons with the above guidelines are inconsistent, however treating high-risk bariatric 
patients seems to have a positive effect in adherence. Wu et al reported that 95% of bariatric 
surgeon comply with guidelines, while ENDORSE trial proved that only 58,5% of all 
surgical patients in risk for VTE receive prophylaxis.  
4.2.3 The role of inferior vena cava filters 
The prophylactic use of inferior vena cava filters (IVCF) remains controversial. Although 
recent studies report lower incidence of DVT and PE, other suggest that IVCF may reduce the 
rate of PE, but increase the incidence of DVT. Risk and complications deriving from the 
implantation of such a device should not be underestimated. Inferior Vena Cava, filter 
breakage, caval perforation, insertion site hematoma and infection have been reported. Based 
on the above, American Society of Hematology stated that the evidence to support the efficacy 
of IVCF in bariatric surgery is insufficient (Grade 2C recommendation against their use). 
4.3 Diagnosis of venous thromboembolism 
4.3.1 Clinical findings 
Presenting symptoms of VTE are rather non-specific (dyspnea, chest pain, tachypnea), 
rendering the clinical diagnosis difficult. The key to early detection of VTE in bariatric 
patients is the high degree of vigilance for clinical features of DVT or PE. Physical 
examination may reveal increased respiratory rate, rales, wheeze, pleural friction rub, 
cyanosis, tachycardia, loud second heart sound, sings of DVT (oedema, redness, Homan’s 
sign- pain on passive dorsiflexion of the ankle) and temperature above 38,5oC. Syncope and 
severe hypotension when present should be considered as signs of hemodynamic 
compromise. 
In obese patients typical clinical findings of DVT or PE can be underestimated, as some of 
them (edema of lower extremity, tachycardia, dyspnea, tachypnea) pre-exist, due to obesity 
related co-morbidities, such as cardiac or respiratory failure, varicose veins, obesity related 
hypoventilation syndrome.  
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Clinical prediction rules were established in order to overcome the above limitations and 
provide effective risk stratification of VTE. Wells Score and Revised Geneva Score assess the 
clinical probability of VTE based on patient’s risk factors and clinical findings.  
4.3.2 Laboratory findings 
The role of arterial blood gas (ABG) in the diagnosis of VTE is rather limited. Respiratory 
alkalosis and hypoxemia constitute common but non-specific findings and although their 
presence should raise suspicion, cannot be used solely for the confirmation of the diagnosis.  
D-dimers blood test detects a fibrin degradation product and has a high negative predictive 
value. In bariatric patients has limited value only to exclude VTE, as recent surgery, 
inflammation and trauma can induce false positive readings.  
4.3.3 Imaging studies 
Several diagnostic imaging studies can be performed in bariatric population, although 
limitations occur. 
Electrocardiogram (ECG) in acute pulmonary embolism can reveal sinus tachycardia, ST 
segment depression and signs of right ventricular strain (more commonly incomplete right 
bundle branch block). Echocardiogram may detect right ventricular dysfunction. The high 
prevalence of cardiovascular diseases (coronary heart disease, left ventricular hypertrophy, 
atrial fibrillation, arrhythmias) in obese patients renders ECG and echocardiogram 
diagnostic tools of limited value.  
Chest radiograph in acute pulmonary embolism may appear normal, while rarely, 
infiltrates, pleural effusion, atelectasis may be present. Consequently, chest radiograph is 
more useful in the exclusion of other pathological entities (pneumonia, pneumothorax) that 
may present with the same clinical picture with pulmonary embolism. 
In the detection of DVT, Duplex Doppler Ultrasound remains the standard noninvasive 
examination for the visualization of thrombus, although when performed in obese patients 
may have reduced accuracy.  
Chest Spiral CT has recently replaced pulmonary angiography and is now considered as the 
gold standard in the diagnosis of PE. However, special equipment must be available for 
morbidly obese patient, given the weight limitation of the conventional ones.  
5. Differential diagnosis 
Pathological entities that present with the same clinical features and sings as venous 
thromboembolism and should be part of the differential diagnosis are: pneumonia, pleural 
effusion, pneumothorax, congestive heart failure, and cardiac ischemia, exacerbation of 
chronic obstructive pulmonary disease, asthma and pulmonary edema.  
Furthermore, differential diagnosis of PE after bariatric surgery should include anastomotic 
leakage, which may also present with tachycardia, fever, chest pain and respiratory 
insuffiency. An upper gastrointestinal study or surgical intervesion may be necessary in 
order to exclude such a complication.  
6. Treatment of venous thromboembolism 
European Society of Cardiology guidelines and American Heart Association statement 
provide evidence-based therapeutic strategies of VTE. Hemodynamic and respiratory 
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support is vital in patients presenting with PE and right ventricle dysfunction. Standard 
treatment remains the administration of UFH, LMWH and fontaparinux with the 
considerations mentioned in the prophylactic use of these agents. Data confirming the safety 
of weight-based dosage of LMWH are insufficient. Performance of thrombolysis, surgical 
pulmonary embolectomy, percutaneous catheter embolectomy and IVCF should be guided 
by evidence-based indications. In the absence of nationwide established guidelines 
standardized to this special surgical population, potential risk of all the above 
pharmacological and mechanical means should be taken into account when treating 
bariatric patients.  
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